Literature DB >> 20309680

Detection of low-grade prosthetic joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results.

Vera Graute1, Markus Feist, Sebastian Lehner, Alexander Haug, Peter Ernst Müller, Peter Bartenstein, Marcus Hacker.   

Abstract

PURPOSE: Low-grade joint infections are characterized by infiltration of granulocytes, which mediate aspects of inflammatory changes. We evaluated retrospectively the contribution of SPECT/CT as an addition to planar scintigraphy with (99m)Tc-labelled antigranulocyte antibodies for diagnosing and localizing low-grade joint infections.
METHODS: Planar scintigraphy using (99m)Tc-labelled antigranulocyte BW 250/183 antibodies was performed in 31 patients with suspected joint infections at 5 min, 5 h and 24 h after injection, with additional SPECT/CT performed 6 h after injection. With reference to gold standard clinical data, we assessed the diagnostic sensitivity of scintigraphy alone and in conjunction with SPECT/CT.
RESULTS: Joint infections were diagnosed clinically in 9 of the 31 patients (1 hip and 8 knee prostheses). Planar scintigraphy revealed 6 true-positives, 13 true-negatives, 9 false-positives and 3 false-negative results, indicating sensitivity, specificity, positive and negative predictive values of, respectively, 0.66, 0.60, 0.4 and 0.81. With the addition of SPECT images, corresponding sensitivity, specificity, positive and negative predictive values increased to 0.89, 0.45, 0.40 and 0.91. Implementation of fused SPECT/CT led to a further increase to 0.89, 0.73, 0.57 and 0.94.
CONCLUSION: Relative to planar scintigraphy, SPECT with and without CT substantially improved the utility of imaging with (99m)Tc-labelled antigranulocyte antibodies for diagnosis and localization of suspected joint infections. Optimal accuracy was obtained through image fusion, which permitted anatomical allocation of foci of pathological tracer accumulation as well as providing information on the extent of the infection. This imaging method seems suited for selection of patients requiring surgical therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309680     DOI: 10.1007/s00259-010-1431-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

1.  Localization and diagnosis of septic endoprosthesis infection by using 99mTc-HMPAO labelled leucocytes.

Authors:  G Wolf; R M Aigner; T Schwarz; M P Lorbach
Journal:  Nucl Med Commun       Date:  2003-01       Impact factor: 1.690

2.  Imaging of infected total arthroplasty with Tc-99m-labeled antigranulocyte antibody Fab'fragments.

Authors:  Thomas von Rothenburg; Martin Schoellhammer; Josef Schaffstein; Odo Koester; Gebhard Schmid
Journal:  Clin Nucl Med       Date:  2004-09       Impact factor: 7.794

Review 3.  Total hip arthroplasty sepsis. Prevention and diagnosis.

Authors:  R H Fitzgerald
Journal:  Orthop Clin North Am       Date:  1992-04       Impact factor: 2.472

4.  Role of 99mTc Sulesomab in the diagnosis of prosthetic joint infections.

Authors:  Karthikeyan P Iyengar; Sobhan Vinjamuri
Journal:  Nucl Med Commun       Date:  2005-06       Impact factor: 1.690

Review 5.  FDG-PET in patients with painful hip and knee arthroplasty: technical breakthrough or just more of the same.

Authors:  P Reinartz
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-02       Impact factor: 2.346

6.  Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery.

Authors:  V Ivanćević; C Perka; O Hasart; D Sandrock; D L Munz; V Ivanèeviae
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02-23       Impact factor: 9.236

7.  Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.

Authors:  M J Spangehl; B A Masri; J X O'Connell; C P Duncan
Journal:  J Bone Joint Surg Am       Date:  1999-05       Impact factor: 5.284

8.  Comparison of Tc-99m-labelled antileukocyte fragment Fab' and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study.

Authors:  A Devillers; E Garin; J L Polard; J Y Poirier; C Arvieux; S Girault; A Moisan; P Bourguet
Journal:  Nucl Med Commun       Date:  2000-08       Impact factor: 1.690

Review 9.  Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies--a meta-analysis.

Authors:  Emilios E Pakos; Thomas A Trikalinos; Andreas D Fotopoulos; John P A Ioannidis
Journal:  Radiology       Date:  2006-11-07       Impact factor: 11.105

10.  Diagnosis of orthopedic infection in clinical practice using Tc-99m sulesomab (antigranulocyte monoclonal antibody fragment Fab'2).

Authors:  A Garcia Vicente; M Almoguera; J C Alonso; A Jimenez Heffernan; A Gomez; P I Contreras; J Martin-Comin
Journal:  Clin Nucl Med       Date:  2004-12       Impact factor: 7.794

View more
  20 in total

Review 1.  SPECT/CT in patients with painful knee arthroplasty-what is the evidence?

Authors:  Michael T Hirschmann; Johann Henckel; Helmut Rasch
Journal:  Skeletal Radiol       Date:  2013-06-11       Impact factor: 2.199

2.  4D-SPECT/CT in orthopaedics: a new method of combined quantitative volumetric 3D analysis of SPECT/CT tracer uptake and component position measurements in patients after total knee arthroplasty.

Authors:  Helmut Rasch; Anna L Falkowski; Flavio Forrer; Johann Henckel; Michael T Hirschmann
Journal:  Skeletal Radiol       Date:  2013-05-22       Impact factor: 2.199

Review 3.  Prosthetic joint infections: radionuclide state-of-the-art imaging.

Authors:  Filip Gemmel; Hans Van den Wyngaert; Charito Love; M M Welling; Paul Gemmel; Christopher J Palestro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-24       Impact factor: 9.236

4.  [Importance of SPECT/CT for knee and hip joint prostheses].

Authors:  K Strobel; I Steurer-Dober; M W Huellner; P Veit-Haibach; B Allgayer
Journal:  Radiologe       Date:  2012-07       Impact factor: 0.635

5.  [SPECT/CT diagnostics for skeletal infections].

Authors:  B Klaeser; M Spanjol; T Krause
Journal:  Radiologe       Date:  2012-07       Impact factor: 0.635

Review 6.  Prosthetic joint infections in the elderly.

Authors:  G De Angelis; N T Mutters; L Minkley; F Holderried; E Tacconelli
Journal:  Infection       Date:  2015-06-22       Impact factor: 3.553

Review 7.  Pathogen-Specific Bacterial Imaging in Nuclear Medicine.

Authors:  Alvaro A Ordonez; Sanjay K Jain
Journal:  Semin Nucl Med       Date:  2017-12-14       Impact factor: 4.446

Review 8.  Nuclear medicine and the failed joint replacement: Past, present, and future.

Authors:  Christopher J Palestro
Journal:  World J Radiol       Date:  2014-07-28

9.  Symptomatic versus asymptomatic knees after bilateral total knee arthroplasty: what is the difference in SPECT/CT?

Authors:  R Awengen; H Rasch; F Amsler; M T Hirschmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-15       Impact factor: 9.236

10.  99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells.

Authors:  Wolf S Richter; Velimir Ivancevic; Johannes Meller; Otto Lang; Dominique Le Guludec; István Szilvazi; Holger Amthauer; Florence Chossat; Amel Dahmane; Carsten Schwenke; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.